GlassScriptPhysician profile
Andrew D Rosenthal
NPI 1336101211
$12,671.07
in general payments reported to CMS, 2019-2025
49 companies · $1,089 in 2025
The $1,089 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,187 · 2020: $713 · 2021: $3,149 · 2022: $2,507 · 2023: $2,320 · 2024: $1,706 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,109 · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,109.21 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,509.51 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $1,336.28 | 2019-2025 | |
| Boston Scientific Corporation | $1,111.98 | 2019-2024 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Watchman Access System |
| Abbott Laboratories | $783.34 | 2019-2025 | Aveir, Assurity, Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $735.27 | 2019-2024 | Farxiga, Andexxa, Wainua |
| Shockwave Medical, INC | $723.90 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $600.74 | 2021-2025 | Impella |
| Amgen INC. | $600.44 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $536.76 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $443.45 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $433.18 | 2021-2024 | Verquvo, Belsomra, Januvia |
| Medtronic, INC. | $430.17 | 2021-2023 | Micra, Resolute Onyx, Cobalt Dr Mri Surescan |
| Amarin Pharma, INC. | $393.23 | 2019-2022 | |
| Cardiovascular Systems INC. | $380.47 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.58 | 2019-2024 | Jardiance |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $259.96 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $224.94 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.05 | 2019-2023 | Lifevest |
| Biosense Webster, INC. | $184.41 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Heartflow, INC. | $175.04 | 2019-2025 | |
| Biotronik INC. | $151.37 | 2019-2025 | Selectra, Amvia Edge, Biomonitor |
| Novo Nordisk INC | $118.01 | 2021-2024 | Wegovy |
| Esperion Therapeutics, INC. | $102.25 | 2021-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $90.46 | 2019-2025 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $68.46 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $65.86 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $63.81 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Alnylam Pharmaceuticals INC. | $60.66 | 2025 | Onpattro |
| Astellas Pharma US INC | $49.50 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $48.38 | 2022-2024 | Uptravi, Opsumit |
| Portola Pharmaceuticals, LLC | $47.18 | 2019-2020 | |
| Nuwellis, INC. | $36.14 | 2019 | |
| Penumbra, INC. | $36.07 | 2022-2024 | Indigo System |
| Alexion Pharmaceuticals, INC. | $31.29 | 2022 | |
| Cleerly, INC. | $29.08 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Edwards Lifesciences Corporation | $26.41 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Acutus Medical, INC. | $25.64 | 2021 | |
| Acumed LLC | $24.67 | 2025 | Ribloc, Biobridge |
| Impulse Dynamics (USA) INC. | $22.52 | 2024 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $22.38 | 2023 | |
| Corcept Therapeutics | $17.38 | 2025 | Korlym |
| Philips North America LLC | $15.60 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.54 | 2020 | |
| Cordis US Corp. | $15.44 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $15.17 | 2023 | Arcalyst |
| Baxter Healthcare | $14.70 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Preventice Services, LLC | $14.45 | 2021 | |
| Livanova USA, INC. | $13.09 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rosenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.